Cite
MLA Citation
W. Yang et al.. “IDF21-0323 Safety and efficacy of IBI362 (LY3305677) in Chinese patients with T2D: A randomized, placebo-controlled phase 1b study.” Diabetes research and clinical practice, vol. 186, 2022, p. . http://access.bl.uk/ark:/81055/vdc_100156439250.0x000045